Bi
BigHat Bio
San Mateo CAFounded 201940 employees
Private CapbiotechPrivateOncology
Platform: ML Ab Design
Market Cap
N/A
All Drugs
4
Clinical Trials
8
Failed / Terminated
2
FDA Approved
1
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Zanutuximab | BIG-8335 | Phase 2 | 1 | TYK2 | GBMWilms | ||
| BIG-7200 | BIG-7200 | Phase 1 | 2 | KRASG12D | ASMigraine | ||
| Mavucagene | BIG-2789 | NDA/BLA | 2 | JAK2 | CLL | ||
| BIG-3814 | BIG-3814 | Approved | 3 | WRN | Hemophilia A |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (7)